Suitability of a Minipig Model in Assessing Clinical Bioperformance of Matrix and Multiparticulate Extended-Release Formulations for a BCS Class III Drug Development Candidate-Reference-Cited by-同舟云学术

Suitability of a Minipig Model in Assessing Clinical Bioperformance of Matrix and Multiparticulate Extended-Release Formulations for a BCS Class III Drug Development Candidate

Published:2014-02 Issue:2 Volume:103 Page:636-642
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Kesisoglou Filippos,Xie Iris Huizhi,Manser Kimberly,Wu Yunhui,Hardy Ian,Fitzpatrick Shaun

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference11 articles.

1. Immediate release oral dosage forms: Formulation screening in the pharmaceutical industry in Oral Drug Absorption: Prediction and Assessment;Wu,2010

2. Comparison of canine and human gastrointestinal physiology;Dressman;Pharm Res,1986

3. The RETHINK project on minipigs in the toxicity testing of new medicines and chemicals: Conclusions and recommendations;Forster;J Pharmacol Toxicol Methods,2010

4. A physiologically based pharmacokinetic model of the minipig: Data compilation and model implementation;Suenderhauf;Pharm Res,2013

5. Gastric emptying of tablets and granules in humans, dogs, pigs, and stomach-emptying-controlled rabbits;Aoyagi;J Pharm Sci,1992

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple-reaction monitoring (MRM) LC–MS/MS quantitation of venlafaxine and its O-desmethyl metabolite for a preclinical pharmacokinetic study in rabbits;Scientific Reports;2022-06-04

2. Preclinical Evaluation – Animal Models to Evaluate MR Formulations;Oral Drug Delivery for Modified Release Formulations;2022-04-08

3. Porcine Prediction of Pharmacokinetic Parameters in People: A Pig in a Poke?;Drug Metabolism and Disposition;2018-08-31

4. The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review;Journal of Pharmacy and Pharmacology;2018-04-10

5. Utility of PBPK Absorption Modeling to Guide Modified Release Formulation Development of Gaboxadol, a Highly Soluble Compound With Region-Dependent Absorption;Journal of Pharmaceutical Sciences;2016-02